Filter
846
Text search:
assays
Featured
Recommendations
124
New Publications
204
Language
Document type
No document type
448
Guidelines
208
Studies & Reports
92
Manuals
38
Fact sheets
28
Strategic & Response Plan
21
Training Material
5
Situation Updates
3
Resource Platforms
2
Online Courses
1
Countries / Regions
India
47
Western and Central Europe
29
Global
28
Germany
17
Eastern Europe
16
Latin America and the Carribbean
15
Africa
15
South Africa
14
Kenya
13
Russia
12
Uganda
11
Tanzania
11
Sierra Leone
10
Nigeria
10
Brazil
10
East and Southern Africa
10
West and Central Africa
10
Liberia
9
Ukraine
9
Ethiopia
8
Malawi
8
Mozambique
8
Middle East and North Africa
8
Bangladesh
7
Namibia
6
Colombia
6
Nepal
5
Zambia
5
Cambodia
5
Angola
5
USA
4
Syria
4
Argentina
4
Peru
4
South–East Asia Region
4
Venezuela
4
Burkina Faso
3
Senegal
3
Congo, Democratic Republic of
3
Cameroon
3
Philippines
3
Rwanda
3
Sudan
3
Lesotho
3
Myanmar / Burma
3
Chile
3
Yemen
3
Asia
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Ghana
2
Niger
2
Zimbabwe
2
Somalia
2
Pakistan
2
Iraq
2
Jordan
2
Afghanistan
2
Lebanon
2
Egypt
2
Chad
2
Indonesia
2
Ecuador
2
El Salvador
2
Bolivia
2
Libya
2
Madagascar
2
Eastern Europe and Central Asia
2
Qatar
2
Guinea
1
Guinea-Bissau
1
Morocco
1
Haiti
1
Turkey
1
China
1
Mauritania
1
Benin
1
Dominican Republic
1
Eswatini/ Swaziland
1
Switzerland
1
Cuba
1
Honduras
1
Guatemala
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Western Pacific Region
1
Bhutan
1
Palestine
1
Djibouti
1
Mongolia
1
Congo-Brazzaville
1
Tajikistan
1
Estonia
1
Romania
1
Moldova
1
Iran
1
Kazakhstan
1
Georgia
1
North America
1
Jamaica
1
France
1
Tunisia
1
Portugal
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
234
Clinical Guidelines
150
Pharmacy & Technologies
48
Public Health
37
Women & Child Health
13
Key Resources
11
Capacity Building
2
Toolboxes
TB
169
COVID-19
122
HIV
108
Rapid Response
56
NTDs
49
Ebola
23
Zika
23
AMR
23
Pharmacy
15
Refugee
14
Polio
10
NCDs
10
Planetary Health
9
Conflict
5
Specific Hazards
5
Mental Health
3
Caregiver
3
Natural Hazards
2
Global Health Education
2
Cholera
1
Health Financing Toolbox
1
В этом документе представлены временные рекомендации для лабораторий и других заинтересованных сторон,
принимающих участие в диагностической работе для выявлен
...
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов
...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir
...
18 Janaury 2021
EU/EEA Member States and the UK have increased their laboratory capacity tremendously over the past 11 months as the majority of the Member States reported sufficient testing capacity until March 2021.
Many countries are adding rapid antigen detection tests (RADT) to their
...
Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19
recommended
ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr
...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha
...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w
...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid
...
The objectives of pertussis surveillance are to:hmonitor disease burden and the impact of the pertussis vaccination programme, with a special focus on understanding the morbidity and mortality in children < 5 years of agehgenerate data to inform vaccine schedule and delivery strategy decisions to optimize the impact of
...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
1 February 2021 to 31 January 2022
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic
...
Au cours de la dernière décennie, les données de séquençage génétique des agents pathogènes ont gagné en importance et contribuent désormais de façon déterminante à la détection et à la maîtrise des flambées de maladies infectieuses, en facilitant la mise au point de
...
En el último decenio, los datos de las secuencias genéticas de los patógenos han adquirido un papel crucial en la detección y el manejo de los brotes de enfermedades infecciosas, contribuyendo al desarrollo de pruebas diagnósticas, medicamentos y vacunas y orientando la respuesta sanitaria.
WHO-2019-nCoV-genomic_sequencing
